NO965468L - Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor - Google Patents

Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor

Info

Publication number
NO965468L
NO965468L NO965468A NO965468A NO965468L NO 965468 L NO965468 L NO 965468L NO 965468 A NO965468 A NO 965468A NO 965468 A NO965468 A NO 965468A NO 965468 L NO965468 L NO 965468L
Authority
NO
Norway
Prior art keywords
treatment
viral infections
prevention
pharmaceutical preparation
well
Prior art date
Application number
NO965468A
Other languages
English (en)
Other versions
NO965468D0 (no
Inventor
Kurt Berg
Soeren Broegger Christensen
Carsten Boye-Knudsen
Chen Ming
Beth Simonsen
Original Assignee
Kurt Berg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurt Berg filed Critical Kurt Berg
Publication of NO965468D0 publication Critical patent/NO965468D0/no
Publication of NO965468L publication Critical patent/NO965468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk preparat for forhindring og/eller behandling av virale infek- sjoner og eventuelle betennelser, om- fattende ett eller flere p-lupeol- derivater, eventuelt i kombinasjon med en forbindelse som frigjør ammoniumioner og/eller i kombinasjon med ett eller flere mono- eller polysulfaterte mono-, oligo- eller polysakkarider, eller analoger og/eller derivater derav. Det farmasøytiske preparat kan være i form av tyggegummier, pastiller, tyggetab- letter, "resoribletter", drops, flate pastiller, geler, munnsalver, oppløs- ninger, slimklebende blandinger eller depot-preparater. Videre beskrives en fremgangsmåte for forhindring og behandling av virale infeksjoner og eventuelle betennelser ved oral til- førsel av det farmasøytiske preparat.
NO965468A 1994-06-20 1996-12-19 Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor NO965468L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK72294 1994-06-20
DK92694 1994-08-09
PCT/DK1995/000256 WO1995035103A1 (en) 1994-06-20 1995-06-20 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof

Publications (2)

Publication Number Publication Date
NO965468D0 NO965468D0 (no) 1996-12-19
NO965468L true NO965468L (no) 1997-02-19

Family

ID=26064526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965468A NO965468L (no) 1994-06-20 1996-12-19 Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor

Country Status (10)

Country Link
EP (1) EP0762876A1 (no)
JP (1) JPH10504279A (no)
KR (1) KR970703759A (no)
CN (1) CN1158566A (no)
AU (1) AU689603B2 (no)
CA (1) CA2193396A1 (no)
EE (1) EE9600190A (no)
FI (1) FI965114A0 (no)
NO (1) NO965468L (no)
WO (1) WO1995035103A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4995597A (en) * 1996-10-23 1998-05-15 Vertex Pharmaceuticals Incorporated Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
ES2162410T3 (es) * 1997-01-09 2001-12-16 Bifodan As Uso de alcohol diclorobencilico para hacer una preparacion para tratamiento topico de inflamacion.
WO1998032443A1 (de) * 1997-01-24 1998-07-30 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
DK1349553T3 (da) * 2001-01-12 2007-01-08 Bsp Pharma As Dihydro-triterpener til behandling af virusinfektioner, kardiovaskulær sygdom, inflammation, overfölsomhed eller smerte
FR2822821B1 (fr) * 2001-04-03 2004-05-07 Pharmascience Lab Extrait de coques de graines de lupin contenant du lupeol, en particulier extrait riche en lupeol et son procede de preparation
CN104761460B (zh) * 2015-03-26 2017-06-20 苏州沪云肿瘤研究中心股份有限公司 蓝萼甲素衍生物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV

Also Published As

Publication number Publication date
JPH10504279A (ja) 1998-04-28
EE9600190A (et) 1997-06-16
KR970703759A (ko) 1997-08-09
FI965114A (fi) 1996-12-19
CA2193396A1 (en) 1995-12-28
FI965114A0 (fi) 1996-12-19
EP0762876A1 (en) 1997-03-19
WO1995035103A1 (en) 1995-12-28
AU2734095A (en) 1996-01-15
AU689603B2 (en) 1998-04-02
NO965468D0 (no) 1996-12-19
CN1158566A (zh) 1997-09-03

Similar Documents

Publication Publication Date Title
US4956385A (en) Method for reducing the duration of the common cold
CA2059865A1 (en) Pharmaceutical Compositions Containing Orally Absorbable Glycosaminoglycans
NO975632L (no) Dinukleotider som er nyttige for behandling av lungesykdom
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
TR200100569T2 (tr) Mukozaya yapışan (muko-adhesif) oral sıvı bileşimler
PT80079B (pt) Processo para a preparacao de composicoes farmaceuticas anti-virus contendo 2-dietilamino-2',6'-acetoxilida (lidocaina)
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
CA2209167A1 (en) Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
EP1123696A4 (en) COMPOSITIONS FOR ORAL CAVITY
EP0173092A3 (en) Anti viral composition
NO965468L (no) Farmasöytisk preparat for forhindring og/eller behandling av virale infeksjoner og eventuelle inflammasjoner, så vel som en behandlingsmetode derfor
CA2318260A1 (en) Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
JPS57165312A (en) Production of oral composition
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
WO2004021985A3 (en) Verifiable absorption drug delivery form based on cyclodextrins
ES2196779T3 (es) Composiciones farmaceuticas.
ES8301631A1 (es) Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.
TR200100566T2 (tr) Mukozaya yapışan(muko-adhesif)oral sıvı bileşimler
JP2005509007A5 (no)
DE69103724D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
SU1703118A1 (ru) Способ лечени герпетического стоматита у детей
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application